Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats
Though osteoporosis is a significant cause of disability worldwide, treatment with pharmacologic agents decreases risk of fragility fracture. Though these treatments act through the bone remodeling system to improve bone mass, it is unclear if they alter the response of bone to mechanical loading at...
Main Authors: | Amber Rath Stern, Xiaomei Yao, Yong Wang, Amanuel Berhe, Mark Dallas, Mark L. Johnson, Wei Yao, Donald B. Kimmel, Nancy E. Lane |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Bone Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235218721830010X |
Similar Items
-
Bone Density and Cortical Thickness in Normal, Osteopenic, and Osteoporotic Sacra
by: Andrew M. Richards, et al.
Published: (2010-01-01) -
Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes
by: H. Allison, et al.
Published: (2020-11-01) -
Diagnosis of osteopenic syndrome. Osteopenic syndrome in bronchial asthma patients
by: O. P. Zorkaltseva, et al.
Published: (2006-09-01) -
Dynamics of estrogen receptor-α in osteocytes : effects of mechanical strain
by: Ehrlich, Paula Jeanne
Published: (2002) -
Pharmaco-therapy optimization of osteoporosis and osteopenic syndrome in patients with vibratory disease of common and local impact
by: Aleshechkina Е.Е., et al.
Published: (2013-03-01)